AZD1775 Increases Sensitivity to Olaparib and Gemcitabine in Cancer Cells with p53 Mutations.
Meng X, Bi J, Li Y, Yang S, Zhang Y, Li M, Liu H, Li Y, Mcdonald ME, Thiel KW, Wen KK, Wang X, Wu M, Leslie KK.
Meng X, et al. Among authors: wu m.
Cancers (Basel). 2018 May 19;10(5):149. doi: 10.3390/cancers10050149.
Cancers (Basel). 2018.
PMID: 29783721
Free PMC article.